You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

PROAMATINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Proamatine, and when can generic versions of Proamatine launch?

Proamatine is a drug marketed by Takeda Pharms Usa and is included in one NDA.

The generic ingredient in PROAMATINE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Proamatine

A generic version of PROAMATINE was approved as midodrine hydrochloride by MYLAN PHARMS INC on September 10th, 2003.

  Try a Trial

Summary for PROAMATINE
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 137
Clinical Trials: 13
Patent Applications: 2,013
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in PROAMATINE?PROAMATINE excipients list
DailyMed Link:PROAMATINE at DailyMed
Drug patent expirations by year for PROAMATINE
Recent Clinical Trials for PROAMATINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Liver Institute, EgyptN/A
Northwell HealthPhase 4
National Heart, Lung, and Blood Institute (NHLBI)Phase 1

See all PROAMATINE clinical trials

US Patents and Regulatory Information for PROAMATINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa PROAMATINE midodrine hydrochloride TABLET;ORAL 019815-001 Sep 6, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Takeda Pharms Usa PROAMATINE midodrine hydrochloride TABLET;ORAL 019815-002 Sep 6, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Takeda Pharms Usa PROAMATINE midodrine hydrochloride TABLET;ORAL 019815-003 Mar 20, 2002 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.